Neuroendocrine Tumor
📧 Sign up to get email alerts when something new happens for Neuroendocrine Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-09-07Clinical Trial Update: Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization [Phase 2]
Phase II study evaluating sunitinib malate after hepatic artery embolization in neuroendocrine and islet cell tumors; the trial is completed…
-
CLINICAL_TRIALS trial_result · 2012-05-18Clinical Trial Update: Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors [Phase 2]
Phase 2 clinical trial evaluating internal radiation therapy for liver metastases from neuroendocrine tumors was terminated.
-
CLINICAL_TRIALS trial_result · 2011-06-29Clinical Trial Update: Safety and Efficacy Study of PTK787/ZK222584 to Treat Metastatic Neuroendocrine Tumors [Phase 2]
Phase 2 safety and efficacy study of PTK787/ZK222584 for metastatic neuroendocrine tumors has completed, per this clinical trial update.
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma [Phase 2]
Phase 2 clinical trial update of Quarfloxin (CX-3543) in patients with low to intermediate grade neuroendocrine tumors completed.
-
CLINICAL_TRIALS trial_result · 2010-12-07Clinical Trial Update: RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma [Phase 2]
A Phase 2 trial evaluating everolimus (RAD001) in combination with octreotide depot in metastatic or unresectable low-grade neuroendocrine t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-10-26Clinical Trial Update: Gastrointestinal Motility in Patients With Neuroendocrine Tumors
Completed clinical trial evaluating gastrointestinal motility in patients with neuroendocrine tumors.
-
CLINICAL_TRIALS trial_result · 2010-02-25Clinical Trial Update: Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features [Phase 1]
A Phase 1 safety study update evaluating Seneca Valley Virus in patients with solid tumors exhibiting neuroendocrine features.
-
CLINICAL_TRIALS trial_result · 2009-10-07Clinical Trial Update: High Dose Somatostatin Analogues in Neuroendocrine Tumors [Phase 2]
A Phase 2 trial evaluating high-dose somatostatin analogues in neuroendocrine tumors has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-28Clinical Trial Update: Thalidomide in Combination With Temodar in Patients With Neuroendocrine Tumors [Phase 2]
A Phase 2 trial evaluating thalidomide in combination with temozolomide (Temodar) for neuroendocrine tumors has completed.
-
CLINICAL_TRIALS trial_result · 2009-02-17Clinical Trial Update: Ga68-DOTA-NOC-PET Imaging of Neuroendocrine Tumors
This entry provides an update on a clinical trial evaluating Ga-68-DOTA-NOC PET imaging for patients with neuroendocrine tumors.
-
CLINICAL_TRIALS trial_result · 2008-06-02Clinical Trial Update: 11C-Acetate PET/CT Non-FDG-Avid Tumors
This clinical trial update discusses the use of 11C-acetate PET/CT for imaging tumors that do not take up FDG. It covers several cancer type…